PubMed 34632687

PubMed ID: 34632687

View on PubMed
Strong and tunable anti-CRISPR/Cas activities in plants.
Authors: Calvache Camilo, Vazquez-Vilar Marta, Selma Sara, Uranga Mireia, Fernández-Del-Carmen Asun, Daròs José-Antonio, Orzáez Diego
Journal: Plant biotechnology journal (Plant Biotechnol J), Vol.20(2), 2022‑Feb

DOI: 10.1101/2020.10.06.327841 PMCID: PMC8219824

Abstract
CRISPR/Cas has revolutionized genome engineering in plants. However, the use of anti-CRISPR proteins as tools to prevent CRISPR/Cas-mediated gene editing and gene activation in plants has not been explored yet. This study describes the characterization of two anti-CRISPR proteins, AcrIIA4 and AcrVA1, in Nicotiana benthamiana. Our results demonstrate that AcrIIA4 prevents site-directed mutagenesis in leaves when transiently co-expressed with CRISPR/Cas9. In a similar way, AcrVA1 is able to prevent CRISPR/Cas12a-mediated gene editing. Moreover, using a N. benthamiana line constitutively expressing Cas9, we show that the viral delivery of AcrIIA4 using Tobacco etch virus is able to completely abolish the high editing levels obtained when the guide RNA is delivered with a virus, in this case Potato virus X. We also show that AcrIIA4 and AcrVA1 repress CRISPR/dCas-based transcriptional activation of reporter genes. In the case of AcrIIA4, this repression occurs in a highly efficient, dose-dependent manner. Furthermore, the fusion of an auxin degron to AcrIIA4 results in auxin-regulated activation of a downstream reporter gene. The strong anti-Cas activity of AcrIIA4 and AcrVA1 reported here opens new possibilities for customized control of gene editing and gene expression in plants.
Publication Types
Journal Article Research Support, Non-U.S. Gov't
Keywords
Nicotiana benthamiana AcrIIA4 AcrVA1 anti-CRISPR/Cas12a anti-CRISPR/Cas9 gene expression regulation
Related Articles